Joel Walker Scientific Meeting Series

Joel Walker

Joel Walker, an adult with FA, passed away from complications of head and neck cancer in November 2016, at the age of 33. Joel was a talented student, good at sports, sociable and happy. Research into treatment for FA was a high priority for Joel, along with the hope that he could help others, so he left a large part of his estate to the Fanconi Anemia Research Fund. In honor of their son, Joel’s parents, Nigel and Ann Walker, created the Joel Walker Scientific Meeting Series. The goal of the series is to bring experts from various fields together to focus on specific areas of FA research and treatment. The generous bequest from Joel’s estate and on-going support from the Walker family make this important series of scientific meetings possible.

The first meeting, Head and Neck Cancer in FA: Developing Guidelines to Maximize Therapeutic Outcomes, took place in April 2018 ​at the University of Pittsburgh Medical Center.